You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This exciting resource takes readers inside the highly visual science of hematology, combining abundant, high-quality color illustrations with expert descriptions of the most recent and clinically relevant advances in the field. Essential content focuses on the hematologic malignancies, emphasizing how an improved understanding of these disorders has served as a springboard to the development of effective anticancer treatments. Discussions by expert editors and contributors review Hodgkin's and non-Hodgkin's lymphomas, plasma cell disorders, myeloid disorders, coagulopathies, anemias, and the role of cytokines and stem cells. Hundreds of clear, vibrant illustrations enhance diagnostic accuracy and guide treatment decisions.
A compassionate guide to the cancer journey, from screening and prevention to diagnosis and recovery. A cancer diagnosis can change our lives and the lives of our loved ones in an instant. It leaves us seeking answers to myriad questions and searching for hope. In The Cancer Journey, Dr. Chadi Nabhan demystifies this complex disease and offers a compassionate guide to understanding your diagnosis and treatment options. With decades of experience treating oncology patients, Dr. Nabhan answers your essential questions about cancer, including how it develops, how it is diagnosed, how it is treated, and how to prevent it from returning. He provides suggestions for how readers can prepare for the...
Effective care of the cancer patient increasingly involves systemic treatment, and as the range of available therapeutic agents continues to expand, the medical oncologist must be fully aware of the combinations. This new edition provides a practical overview of the many treatment choices, and has been fully updated, including discussion of new classification systems, anticancer agents and treatment protocols.
Billions of dollars are spent every year on research into targeted therapies for cancer. That’s why it’s more than ever crucial for the thousands of scientists working in the field to keep right up to date with the cutting edge. This fascinating collection of material goes a long way to helping them do so, featuring as it does contributions to a crucial international meeting in Italy. The meeting provided a forum for scientists and clinicians working in cancer drug discovery and therapy to share their opinions and experiences. The text here offers readers an overview of diverse approaches, ranging from drug discovery to cellular therapy. Overall, the book addresses the key question of whether ultimately targeted therapy in cancer will be a myth or a reality.
The mature T and NK cell lymphomas are rare, comprising approximately 10% of all malignant lymphomas. The incidence of T-cell lymphoma is variable around the world, with a higher incidence compared to B-cell lymphomas in the Asian basin. While the overall incidence of B-cell lymphomas has begun to decline in the United States, the incidence of T-cell lymphomas continues to rise. Over the last decade, a number of novel agents have been developed which target T-cell lymphomas and studies have identified novel genes and pathways associated with lymphomagenesis in T-cells. This comprehensive volume examines the clinical and biological aspects of the T-cell lymphoproliferative disorders in adults...
The fourth volume in this outstanding series of annual updates in oncology, Progress in Oncology 2004 addresses fifteen of the most important "hot topics" in the field. Under the careful direction of Drs. DeVita, Hellman, and Rosenberg, each volume in this exciting series presents concise summaries of the state of the art in cancer basic science and clinical application, written by 15 of the top researchers and clinicians in the world.As with all the volumes in the series, PIO 2004 covers critical issues in clinical cancer care and research in a scholarly though readable style. Chapters on advances in treatment and diagnosis, including DNA microarrays, growth factor receptors, new applications of thalidomide, and allografting in NHL review the state of the art in these emerging fields. Top experts provide timely overviews of focused ultrasound therapy, hormone therapy for prostate cancer, and CHOP and rituxin for DLCL. In a special surgery section, world-class authorities discuss approaches to rectal cancer. These and other rigorously referenced chapters make PIO 2004 an indispensable new oncology resource.
MALT Lymphomas is a multidisciplinary book that covers all the aspects of MALT lymphomas, from the molecular biology, the aetiology and the pathology, to all the possible therapeutic approaches. Extranodal marginal zone B cell lymphoma of MALT type (MALT lymphoma) is one of the lymphoma subtypes that has allowed us some of the most interesting steps forward in the understanding and treatment of human cancers. The eight contributions have been written by a team of international experts and represent an essential reading for oncologists, haematologists, gastroenterologists, pathologists and all the other physicians and researchers involved in cancer. The book is also supported by a series of figures illustrating the histology and the clinical features and the treatment.
Effective care of the cancer patient increasingly involves systemic treatment, and as the range of available therapeutic agents continues to expand, the medical oncologist must be fully aware of the rationale for choosing specific drugs and combinations. Textbook of Medical Oncology, 4th edition, is written by a highly acclaimed list of internation
Written by a team of leading authorities in pathogenesis, diagnostic techniques, and clinical management strategies in myelodysplastic syndrome (MDS), this text provides a concise, easy-to-follow review of the advances in the science, classification, diagnosis, and management of the condition. An ideal source for hematologists, oncologists, and can